Overview
HUM market data
Price History
HUM price chart
Valuation & Profitability
- P/E (TTM)
- 43.34 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $9.83 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.75 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 87.2% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $163.11 – $415.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $49K · P/B 1.74 · P/S 0.36.
Company news
2.6 Million People Lost Their Medicare Advantage Plan This Year: Here's How To Avoid Being Caught Off Guard For 2027Benzinga · Jul 20, 2026, 9:24 PM
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage LossesBenzinga · Jul 16, 2026, 5:24 PM
Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027Benzinga · Jul 16, 2026, 1:16 PM
TD Cowen Maintains Hold on Humana, Raises Price Target to $350Benzinga · Jul 14, 2026, 3:28 PM
Truist Securities Maintains Hold on Humana, Raises Price Target to $415Benzinga · Jul 14, 2026, 1:31 PM
Humana shares are trading higher after Wells Fargo upgraded the stock from Equal-Weight to Overweight and raised its price target from $227 to $502.Benzinga · Jul 13, 2026, 3:01 PM
Wells Fargo Upgrades Humana to Overweight, Raises Price Target to $502Benzinga · Jul 13, 2026, 11:53 AM
RBC Capital Maintains Sector Perform on Humana, Raises Price Target to $415Benzinga · Jul 9, 2026, 5:35 PM
Cantor Fitzgerald Maintains Neutral on Humana, Raises Price Target to $300Benzinga · Jul 7, 2026, 12:01 PM
Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out WednesdayBenzinga · Jun 30, 2026, 12:30 PM